Acidotic cord gasses (arterial umbilical pH < 7.10) · pregnant women in latent phase of labour stimulated with oxytocin for with induction of labour. No exclusion criteria were applied in…
Discontinued intravenous (IV) oxytocin stimulation may leads to higher acidotic cord gasses (arterial umbilical pH < 7.10) compared with continued IV oxytocin stimulation (low certainty).
1 finding from 1 review
Units of SGRQ change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Dyspnoea ‐ CRQ dyspnoea Scale 1 to 7. Higher is better and 0.5 units is a clinically important difference · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse eventsd · patients with chronic obstructive pulmonary disease
1 finding from 1 review
CAT score · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Change in dyspnoea score · patients with chronic obstructive pulmonary disease
2 findings from 1 review
Dyspnoea ‐ change in mMRC Scale 0 to 4. Lower is better and 1 unit is a clinically important difference · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Adverse eventsf · patients with chronic obstructive pulmonary disease
1 finding from 1 review
General health‐related quality of life · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Health‐related quality of life (mental) · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Units of SGRQ change from baseline · patients with chronic obstructive pulmonary disease
1 finding from 1 review
Intervention not reported
UCVA of 20/20 or better at 12 months post treatment · adult participants (≥ 18 years) with myopia
The intervention showed no clear difference in UCVA of 20/20 or better at 12 months post treatment (low certainty).
1 finding from 1 review
RR 0.98 [0.92, 1.05]
Studies not reported
Low
Intervention not reported
Within ± 0.50 D of target refraction at 12 months post treatment · adult participants (≥ 18 years) with myopia
The intervention showed no clear difference in within ± 0.50 D of target refraction at 12 months post treatment (low certainty).
1 finding from 1 review
RR 0.93 [0.84, 1.03]
Studies not reported
Low
Intervention not reported
Loss of 1 or more lines of BSCVA at 12 months post treatment · adult participants (≥ 18 years) with myopia
It is very uncertain whether the intervention changes loss of 1 or more lines of BSCVA at 12 months post treatment (very low certainty).
1 finding from 1 review
RR 3 [0.13, 71.96]
Studies not reported
Very low
Intervention not reported
Mean spherical equivalent at 12 months post treatment · adult participants (≥ 18 years) with myopia
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Intervention not reported
Adverse outcomes ‐ corneal haze score at 12 months (grade 1.0 ‐ more prominent haze that does not interfere with visibility of fine iris details; grade 2.0 ‐ mild obscuration of iris details; grade 3.0 ‐ moderate obscuration of iris and lens; and ... · adult participants (≥ 18 years) with myopia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Adverse outcomes ‐ glare and halo scores at 3 months (grade 0 ‐ none; grade 1 ‐ very low; grade 2 ‐ low; grade 3 ‐ moderate; grade 4 ‐ high; and grade 5 ‐ very high) · adult participants (≥ 18 years) with myopia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Mortality (all‐cause) · people with heart failure
1 finding from 1 review
Intervention not reported
Admission to hospital (all‐cause) · people with heart failure
1 finding from 1 review
Intervention not reported
Disease‐ specific quality of life (QoL) · people with heart failure
1 finding from 1 review